Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis

Published:2016-08 Issue:8 Volume:136 Page:1584-1591
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Yiu Zenas Z.N.^ORCID,Exton Lesley S.,Jabbar-Lopez Zarif,Mohd Mustapa M. Firouz,Samarasekera Eleanor J.,Burden A. David,Murphy Ruth,Owen Caroline M.,Parslew Richard,Venning Vanessa,Ashcroft Darren M.,Griffiths Christopher E.M.,Smith Catherine H.,Warren Richard B.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference46 articles.

1. Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: efficacy and safety results from a Phase II/III randomized controlled study;Asahina;J Dermatol,2010

2. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial;Bachelez;Lancet,2015

3. Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE);Blauvelt;Br J Dermatol,2015

4. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events;Bradburn;Stat Med,2007

5. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials;Dommasch;J Am Acad Dermatol,2011

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basic Susceptibility of Patients with Psoriasis under Systemic Therapy for Respiratory Infections: Data from the German Psoriasis Registry PsoBest;Journal of Clinical Medicine;2024-06-26

2. Systemic therapy for psoriasis and the risk of cutaneous infections;The Journal of Dermatology;2024-04-25

3. Engineered polyspecific antibodies: A new frontier in the field of immunotherapeutics;Immunology;2023-12-23

4. Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice;Journal of Dermatological Treatment;2023-05-29

5. Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing;Biomedicines;2023-02-18